After signing up, you'll start to receive regular news updates from us.
Ingenuity Systems Announces Multi-Year Agreement with Boehringer Ingelheim
Complete the form below to unlock access to ALL audio articles.
Ingenuity Systems announced the signing of a four year agreement with Boehringer Ingelheim for Ingenuity Pathway Analysis (IPA). IPA will be used throughout the Boehringer Ingelheim research and development organization to unlock novel insights from experimental data and as a general tool for biological search and exploration.
The agreement provides global access for Boehringer Ingelheim research scientists to access to the recently released IPA 6, which includes new biological and chemical content, in addition to Path Designer, an award-winning set of tools that more clearly communicates information about networks and pathways.
"We are pleased at this opportunity to become a strategic partner in Boehringer Ingelheim's research and development efforts," stated Jake Leschly, CEO, Ingenuity Systems.
